Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
110929201000001115 | Trastuzumab 420mg powder for solution for infusion vials (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
110929301000001112 | Trastuzumab 420mg powder for solution for infusion vials | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Trazimera 420mg powder for concentrate for solution for infusion vials (Pfizer Ltd) | Is a | True | Trastuzumab 420mg powder for solution for infusion vials | Inferred relationship | Existential restriction modifier | |
Kanjinti 420mg powder for concentrate for solution for infusion vials (Amgen Ltd) | Is a | True | Trastuzumab 420mg powder for solution for infusion vials | Inferred relationship | Existential restriction modifier | |
Trastuzumab 420mg powder for solution for infusion vials 1 vial | Has VMP | True | Trastuzumab 420mg powder for solution for infusion vials | Inferred relationship | Existential restriction modifier | |
Herzuma 420mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd) | Is a | True | Trastuzumab 420mg powder for solution for infusion vials | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets